Patent-pending enzymes to break down common dietary triggers
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
Latest News
Active Founders
Anjie Liu
Interdisciplinary thinker: scientifically-minded; humanist at heart Joint concentration in physics and comparative literature (Harvard 2017), now submerging myself into the intricate world of biology. I've struggled with chronic gut issues for most of my adult life, which led me to developing the current formulation of FODZYME and launching Kiwi Biosciences.
David Hachuel
Formerly co-founder and CEO at auggi.ai, a digital gut health coach for patients with Irritable Bowel Syndrome (IBS). auggi was recently acquired by Seed Health. Completed my MPH in Epidemiology at the Harvard School of Public Health and a Master's in Computer and Information Science at Cornell University.
